Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amezcua-Gálvez Je"'
Autor:
Victor L, Antonio D, Lopez-Garcia Ca, Gomez-Macias Gs, Monroig PdC, Cynthia, Ortiz-Lopez R, Amezcua-Gálvez Je, Mauricio C, Sandra S
Background: The need to identify patients with hormone receptor-positive (HR+) early invasive breast cancer (EIBC) who could benefit from adjuvant chemotherapy has been enhanced with the development of molecular signature tests. However, due to their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5275c25de97cf204dbe8c8699f2117fc
https://doi.org/10.21203/rs.3.rs-452096/v1
https://doi.org/10.21203/rs.3.rs-452096/v1
Autor:
Amezcua-Gálvez JE; Department of Pathology, Tecnologico de Monterrey, Hospital San José, Av. Morones Prieto Poniente 3000 Poniente, Los Doctores, Monterrey, NL 64710, México., Lopez-Garcia CA; Department of Pathology, Tecnologico de Monterrey, Hospital San José, Av. Morones Prieto Poniente 3000 Poniente, Los Doctores, Monterrey, NL 64710, México.; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, TX 77030, USA., Villarreal-Garza C; Breast Cancer Center, Tecnologico de Monterrey, Hospital Zambrano Hellion, Real San Agustín, San Pedro Garza García, NL 66278, México., Lopez-Rivera V; Department of Neurology, UTHealth McGovern Medical School, The University of Texas Health Science Center at Houston, TX 77030, USA., Canavati-Marcos M; Breast Cancer Center, Tecnologico de Monterrey, Hospital Zambrano Hellion, Real San Agustín, San Pedro Garza García, NL 66278, México., Santuario-Facio S; School of Medicine and Health Sciences, Tecnologico de Monterrey, Av Morones Prieto, 3000 Poniente, Los Doctores, Monterrey, Nuevo León, 64710, México., Dono A; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, TX 77030, USA., Monroig-Bosque PDC; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA., Ortiz-López R; School of Medicine and Health Sciences, Tecnologico de Monterrey, Av Morones Prieto, 3000 Poniente, Los Doctores, Monterrey, Nuevo León, 64710, México., Leal-Lopez A; Breast Cancer Center, Tecnologico de Monterrey, Hospital Zambrano Hellion, Real San Agustín, San Pedro Garza García, NL 66278, México., Sofía Gómez-Macías G; Department of Pathology, Tecnologico de Monterrey, Hospital San José, Av. Morones Prieto Poniente 3000 Poniente, Los Doctores, Monterrey, NL 64710, México.; Department of Pathology, Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, NL, 64460 México.
Publikováno v:
Molecular and clinical oncology [Mol Clin Oncol] 2022 Jul 01; Vol. 17 (3), pp. 132. Date of Electronic Publication: 2022 Jul 01 (Print Publication: 2022).
